Compare PAHC & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | EOS |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2014 | 2004 |
| Metric | PAHC | EOS |
|---|---|---|
| Price | $31.02 | $21.91 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $41.25 | N/A |
| AVG Volume (30 Days) | ★ 315.5K | 130.0K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 1883.33 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $833,350,000.00 | N/A |
| Revenue This Year | $17.03 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | $16.77 | ★ N/A |
| Revenue Growth | ★ 4.12 | N/A |
| 52 Week Low | $23.57 | $19.44 |
| 52 Week High | $60.08 | $24.49 |
| Indicator | PAHC | EOS |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 39.53 |
| Support Level | $28.25 | $21.73 |
| Resistance Level | $34.49 | $22.99 |
| Average True Range (ATR) | 1.50 | 0.35 |
| MACD | 0.73 | -0.10 |
| Stochastic Oscillator | 45.30 | 11.90 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.